journal
https://read.qxmd.com/read/37719891/potential-use-of-artificial-intelligence-in-the-histologic-assessment-of-nonalcoholic-steatohepatitis
#1
JOURNAL ARTICLE
Quentin M Anstee
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706191/the-path-to-improving-diversity-equity-and-inclusion-in-endoscopy
#2
JOURNAL ARTICLE
Jennifer A Christie
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706190/insights-into-conditions-that-overlap-with-irritable-bowel-syndrome
#3
JOURNAL ARTICLE
Gerald Holtmann
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706189/exploring-clostridioides-difficile-infection-and-microbiome-therapeutics
#4
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706188/pain-management-in-liver-disease
#5
JOURNAL ARTICLE
James P Hamilton
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706187/clostridioides-difficile-infection-landscape-and-microbiome-therapeutics
#6
JOURNAL ARTICLE
Brent J Gawey, Sahil Khanna
Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea and is common in the community. Both younger individuals who may be healthy otherwise and older individuals with comorbid conditions are at risk for developing CDI, with the predominant risk factor being antibiotic use. Unlike other gastrointestinal infections, CDI is not self-limited, requires antimicrobial therapy, and tends to recur at high rates even without additional risk factor exposure. The goals of CDI management include controlling active symptoms and using a recurrence prevention strategy such as a narrow-spectrum antibiotic, tapered and pulsed regimens, antibody- based therapies (directed against toxin B), or microbiome restoration...
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706186/current-approach-to-postoperative-crohn-s-disease
#7
JOURNAL ARTICLE
Miguel Regueiro
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37706185/understanding-the-current-approaches-in-the-management-of-ibs-c-a-case-study
#8
JOURNAL ARTICLE
Anthony J Lembo
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711663/efficacy-and-safety-outcomes-up-to-4-years-of-treatment-with-filgotinib-200-mg-among-patients-with-ulcerative-colitis-results-from-the-selectionlte-study
#9
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711662/analyses-from-the-phase-3-true-north-study-of-ozanimod-in-uc-patients
#10
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711661/efficacy-of-ustekinumab-for-ulcerative-colitis-through-4-years-final-clinical-and-endoscopy-outcomes-from-the-unifi-long-term-extension
#11
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711660/highlights-in-ulcerative-colitis-from-the-18th-congress-of-ecco-commentary
#12
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711659/single-cell-rnaseq-temporal-analysis-of-ulcerative-colitis-patients-undergoing-tofacitinib-treatment-reveals-a-shift-in-myeloid-cells-towards-pro-inflammatory-phenotypes-in-refractory-patients
#13
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711658/the-effects-of-upadacitinib-on-uc-symptom-resolution-and-fatigue-normalization-in-patients-with-moderately-to-severely-acute-ulcerative-colitis-phase-3-u-achieve-and-u-accomplish-results
#14
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711657/mirikizumab-in-moderately-to-severely-active-colitis
#15
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711656/efficacy-of-etrasimod-on-symptomatic-relief-in-patients-with-ulcerative-colitis-an-analysis-of-the-phase-3-elevate-uc-52-and-elevate-uc-12-trials
#16
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711655/ozanimod-in-uc-patients
#17
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37711654/efficacy-of-etrasimod-on-symptomatic-relief-in-patients-with-ulcerative-colitis-an-analysis-of-the-phase-3-elevate-uc-52-and-elevate-uc-12-trials
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37705847/a-clinical-review-of-mesenteric-panniculitis
#19
JOURNAL ARTICLE
Marianny Sulbaran, Frank K Chen, Francis A Farraye, Jana G Hashash
Mesenteric panniculitis (MP) is a benign condition characterized by chronic inflammation and fibrosis of adipose tissue mainly of the small bowel mesentery. MP is commonly detected incidentally on cross-sectional imaging of the abdomen and can be asymptomatic in up to nearly half of patients. The most frequent clinical symptom reported is abdominal pain, followed by bloating/distention, diarrhea, constipation, vomiting, anorexia, weight loss, fever, malaise, and nausea. On computed tomography, MP is seen as a mass-like area of increased fat attenuation within the small bowel mesentery, usually located in the left upper quadrant of the abdomen...
April 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37705846/green-endoscopy-and-sustainable-care
#20
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
April 2023: Gastroenterology & Hepatology
journal
journal
41233
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.